The Powerball jackpot was $20 million just 3 months ago. Heres how it climbed...
Its going to be pretty bad: This part of the US is hurtling towards a winter...
BREAKING: New downtown Orlando project with 25-story high-rise in the works
Former Fenty administration leaders Ximena Hartsock and Michelle Rhee back...
The CFO of Tyson Foodswho is also the son of the chairmanwas arrested for...
Its going to be pretty bad: This part of the US is hurtling towards a winter...
BREAKING: New downtown Orlando project with 25-story high-rise in the works
Former Fenty administration leaders Ximena Hartsock and Michelle Rhee back...
The CFO of Tyson Foodswho is also the son of the chairmanwas arrested for...
Therapeutics
Business / FinanceBy Business Wire2023-10-31 12:32:00
DiaMedica Therapeutics Inc. DMAC, a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney...
Business / FinanceBy Pr Newswire2023-10-27 20:03:00
- Total quarterly revenue of $217 million, representing 57% year-over-year growth - - 2022 DMD revenue guidance and low end of total revenue guidance...
Business / FinanceBy Globe Newswire2023-11-08 13:00:00
Ovid intends to initiate a Phase 1 study in healthy volunteers in Q4 2022, following the FDA clearance of an Investigational New Drug (IND) application for...
MarketsBy Vandana Singh2023-10-31 15:39:23
Hoth Therapeutics Inc HOTH announced Phase 1b trial data for BioLexa in adult patients with mild-to-moderate atopic dermatitis. Using the SCORAD as a...
MarketsBy Vandana Singh2023-11-04 14:35:48
Rain Therapeutics Inc RAIN announced preliminary data from Phase 2 basket trial evaluating milademetan for MDM2-amplified advanced solid tumors. Treatment...
MarketsBy Vandana Singh2023-11-07 18:23:25
Last November, the FDA signed off Beam Therapeutics Inc's BEAM Investigational New Drug (IND) application for Phase 1/2 trial for BEAM-101 gene therapy for...
MarketsBy Vandana Singh2023-11-08 17:26:45
Avenue Therapeutics Inc ATXI acquired Baergic Bio Inc pursuant to the previously disclosed Share Contribution Agreement with its parent company, Fortress...
MarketsBy Benzinga Insights2023-10-24 16:33:52
CRISPR Therapeutics CRSP has outperformed the market over the past 5 years by 13.48% on an annualized basis producing an average annual return of 21.37%....
TechnologyBy Zacks2023-10-06 12:45:00
For Immediate Release Chicago, IL October 6, 2023 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research...
Business / FinanceBy Benzinga Insights2023-10-19 18:41:08
Plus Therapeutics PSTV is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the...
Business / FinanceBy Benzinga Insights2023-10-26 19:32:01
Travere Therapeutics TVTX is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the...
Business / FinanceBy Benzinga Insights2023-10-31 15:11:07
Aquestive Therapeutics AQST is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the...
Business / FinanceBy Benzinga Insights2023-10-25 20:46:34
Viking Therapeutics VKTX is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the...
Business / FinanceBy Benzinga Insights2023-11-02 19:10:21
Intellia Therapeutics NTLA is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the...
Business / FinanceBy Benzinga Insights2023-11-02 20:16:20
Relay Therapeutics RLAY is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the...
Business / FinanceBy Benzinga Insights2023-11-02 15:18:15
Fate Therapeutics FATE is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the...
Business / FinanceBy Benzinga Insights2023-11-03 18:14:16
Medicenna Therapeutics MDNA is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the...
Business / FinanceBy Benzinga Insights2023-11-07 16:24:57
Voyager Therapeutics VYGR is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the...
MarketsBy Market Beat News2024-09-20 06:08:43
Galectin Therapeutics (NASDAQ:GALT – Get Rating) and Dyne Therapeutics (NASDAQ:DYN – Get Rating) are both small-cap medical companies, but which is the...
Business / FinanceBy Benzinga Insights2023-11-02 14:31:37
Akebia Therapeutics AKBA is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the...